Variant report
Variant | esv3345812 |
---|---|
Chromosome Location | chr20:25059286-25059573 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:62)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr20:25059364-25059414 | GM12892 | blood: | n/a |
2 | chr20:25059364-25059414 | GM12892 | blood: | n/a |
3 | chr20:25059364-25059414 | HMEC | breast: | n/a |
4 | chr20:25059364-25059414 | CMK | blood: | n/a |
5 | chr20:25059364-25059414 | HRCEpiC | kidney: | n/a |
6 | chr20:25059364-25059414 | HepG2 | liver: | n/a |
7 | chr20:25059364-25059414 | ovcar-3 | ovarian: | n/a |
8 | chr20:25059364-25059414 | PFSK-1 | brain: | n/a |
9 | chr20:25059364-25059414 | NH-A | brain: | n/a |
10 | chr20:25059364-25059414 | Hepatocyte | liver: | n/a |
11 | chr20:25059364-25059414 | RPTEC | kidney: | n/a |
12 | chr20:25059364-25059414 | Jurkat | blood: | n/a |
13 | chr20:25059364-25059414 | T-47D | breast: | n/a |
14 | chr20:25059364-25059414 | GM12891 | blood: | n/a |
15 | chr20:25059364-25059414 | GM19239 | blood: | n/a |
16 | chr20:25059364-25059414 | HNPCEpiC | eye: | n/a |
17 | chr20:25059364-25059414 | SKMC | muscle: | n/a |
18 | chr20:25059364-25059414 | HAEpiC | amniotic membrane: | n/a |
19 | chr20:25059364-25059414 | HCM | heart: | n/a |
20 | chr20:25059364-25059414 | AG09319 | gingival: | n/a |
21 | chr20:25059364-25059414 | HEK293 | kidney: | embryo |
22 | chr20:25059364-25059414 | AG04449 | skin: | fetal |
23 | chr20:25059364-25059414 | ProgFib | skin: | n/a |
24 | chr20:25059364-25059414 | AG09309 | skin: | n/a |
25 | chr20:25059364-25059414 | HCT-116 | colon: | n/a |
26 | chr20:25059364-25059414 | PANC-1 | pancreas: | n/a |
27 | chr20:25059364-25059414 | AG10803 | skin: | n/a |
28 | chr20:25059364-25059414 | AG04450 | lung: | fetal |
29 | chr20:25059364-25059414 | BJ | skin: | n/a |
30 | chr20:25059364-25059414 | SAEC | small airway: | n/a |
31 | chr20:25059364-25059414 | HPAEpiC | pulmonary alveolar: | n/a |
32 | chr20:25059364-25059414 | SK-N-SH_RA | brain: | n/a |
33 | chr20:25059364-25059414 | HRPEpiC | eye: | n/a |
34 | chr20:25059364-25059414 | HUVEC | blood vessel: | n/a |
35 | chr20:25059364-25059414 | GM06990 | blood: | n/a |
36 | chr20:25059364-25059414 | NT2-D1 | testis: | n/a |
37 | chr20:25059364-25059414 | AoSMC | blood vessel: | n/a |
38 | chr20:25059364-25059414 | K562 | blood: | n/a |
39 | chr20:25059364-25059414 | HCF | heart: | n/a |
40 | chr20:25059364-25059414 | PrEC | prostate: | n/a |
41 | chr20:25059364-25059414 | IMR90 | lung: | fetal |
42 | chr20:25059364-25059414 | NB4 | blood: | n/a |
43 | chr20:25059364-25059414 | NHDF-neo | bronchial: | n/a |
44 | chr20:25059364-25059414 | ECC-1 | luminal epithelium: | n/a |
45 | chr20:25059364-25059414 | HEEpiC | esophagus: | n/a |
46 | chr20:25059364-25059414 | HRE | kidney: | n/a |
47 | chr20:25059364-25059414 | HL-60 | blood: | n/a |
48 | chr20:25059364-25059414 | A549 | lung: | n/a |
49 | chr20:25059364-25059414 | LNCaP | prostate: | n/a |
50 | chr20:25059364-25059414 | HIPEpiC | eye: | n/a |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
VSX1 | CpG island |
ENSG00000101474 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs564352827 | chr20:25059292-25059293 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs540862655 | chr20:25059338-25059339 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs371478673 | chr20:25059345-25059346 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs376724584 | chr20:25059361-25059362 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs563903530 | chr20:25059364-25059365 | Weak transcription Enhancers | CpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs199755218 | chr20:25059365-25059366 | Weak transcription Enhancers | CpG islandChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs528277026 | chr20:25059375-25059376 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs56157240 | chr20:25059381-25059382 | Weak transcription Enhancers | CpG island | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs552343074 | chr20:25059383-25059384 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs373947722 | chr20:25059403-25059404 | Enhancers Weak transcription Bivalent Enhancer | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs562912096 | chr20:25059406-25059407 | Enhancers Weak transcription Bivalent Enhancer | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs201758357 | chr20:25059411-25059412 | Enhancers Weak transcription Bivalent Enhancer | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs548563431 | chr20:25059414-25059415 | Enhancers Weak transcription Bivalent Enhancer | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs199870772 | chr20:25059419-25059420 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs534477257 | chr20:25059420-25059421 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
16 | rs368840437 | chr20:25059424-25059425 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
17 | rs6138482 | chr20:25059442-25059443 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs200369946 | chr20:25059480-25059481 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
19 | rs75365206 | chr20:25059496-25059497 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
20 | rs201313323 | chr20:25059497-25059498 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
21 | rs144917154 | chr20:25059512-25059513 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
22 | rs555943681 | chr20:25059516-25059517 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
23 | rs138766673 | chr20:25059536-25059537 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
24 | rs200103903 | chr20:25059540-25059541 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
25 | rs12480307 | chr20:25059546-25059547 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs143099682 | chr20:25059564-25059565 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Alagille syndrome | 17576883 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Breast cancer | 16608533 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 17133270 | CNVD |
Thrombophilia | 17576883 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Chordoma | 18071362 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Oral cancer | 21386901 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:25057200-25060600 | Enhancers | Dnd41 | blood |
2 | chr20:25058800-25059400 | Weak transcription | Colonic Mucosa | Colon |
3 | chr20:25058800-25061800 | Weak transcription | Pancreas | Pancrea |
4 | chr20:25059400-25059600 | Bivalent Enhancer | Skeletal Muscle Female | skeletal muscle |
5 | chr20:25059400-25059800 | Enhancers | Colonic Mucosa | Colon |
6 | chr20:25059400-25060200 | Bivalent Enhancer | Rectal Mucosa Donor 29 | rectum |